10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
09/17/2024
5:44 PM | BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
5:41 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
| Form SC 13D/A | |
09/13/2024
4:04 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:16 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
7:42 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
08/20/2024
5:24 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/20/2024
5:27 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:31 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:27 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:29 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:39 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:06 PM | BridgeBio Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
7:16 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/23/2024
3:12 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:38 PM | BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:38 PM | BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:40 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:42 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:42 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:34 PM | AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:35 PM | BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:36 PM | BridgeBio Pharma (Issuer)
Dachille Douglas A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:36 PM | BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:01 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:53 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:13 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:15 PM | BridgeBio Pharma (Filer)
| Form 424B5 | |
03/04/2024
6:00 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
6:15 PM | BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
01/23/2024
9:16 AM | BridgeBio Pharma (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
3:10 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
6:30 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
$5k to $1.3m in just 3 trades (Ad) It doesn’t happen often, but occasionally, something completely unique comes across my radar.
In this case, I’m talking about legal “Insider Trading”.
Traders who have consistently signaled 453% … 610% .. and even 1036%... gains.
And until now they have been doing it completely under the radar.
In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. |
01/08/2024
4:14 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
4:33 PM | BridgeBio Pharma (Subject)
MCCORMICK FRANK (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
3:15 PM | BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:20 PM | BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:15 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
11/17/2023
3:27 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
3:27 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
3:03 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
